Isracann Biosciences Inc. (ISCNF)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 29, 2025
0.00%
Market Cap 177.00
Revenue (ttm) n/a
Net Income (ttm) -3.47M
Shares Out 176.73M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 433
Average Volume 23,552
Open 0.0000
Previous Close n/a
Day's Range 0.0000 - 0.0000
52-Week Range n/a
Beta 14.10
RSI 41.21
Earnings Date n/a

About Isracann Biosciences

Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada. [Read more]

Sector Healthcare
Founded 2010
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol ISCNF
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

CSE Bulletin: Delist - Isracann Biosciences Inc. (IPOT)

Toronto, Ontario--(Newsfile Corp. - le 4 septembre/September 2024) - The common shares of Isracann Biosciences Inc. will be delisted from the CSE at market close today, September 4, 2024. Isracann Bio...

9 months ago - Newsfile Corp

Isracann Biosciences Provides Bi-Weekly Default Status Report

VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) announces that further to its news release dated Septem...

2 years ago - GlobeNewsWire

Isracann Biosciences Announces Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) announces that the filing of its audited annual financ...

2 years ago - GlobeNewsWire

Isracann Bioscience Facilitated Genetics Arrive in Israel

Partner Facility Now Growing Canadian Cannabis Strains Partner Facility Now Growing Canadian Cannabis Strains

2 years ago - GlobeNewsWire

Praesidio signs distribution agreement with Pure Integrative Pharmacy

VANCOUVER, British Columbia, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health med...

3 years ago - GlobeNewsWire

Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board

VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health medi...

3 years ago - GlobeNewsWire

Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement

VANCOUVER, British Columbia, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that it has closed the first tra...

3 years ago - GlobeNewsWire

Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada

VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health medic...

3 years ago - GlobeNewsWire

Isracann Biosciences Renews Leadership to Meet Changing Demands

VANCOUVER, British Columbia, April 15, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that further to its acquisition...

3 years ago - GlobeNewsWire

Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers

VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company's ...

3 years ago - GlobeNewsWire

Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer

VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company's ...

3 years ago - GlobeNewsWire

Searching For Cannabis Catalysts (Podcast Transcript)

Nick Gastevich, one of our favorite commenters on Seeking Alpha, returns to the show to catch us up on the state of cannabis investing. Wave of new states legalizing cannabis now especially important ...

3 years ago - Seeking Alpha

UPDATE - Isracann Signs LOI to Acquire Natural Health Medicine Developer

VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on research...

3 years ago - GlobeNewsWire

Isracann Signs LOI to Acquire Natural Health Medicine Developer

VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on researc...

3 years ago - GlobeNewsWire

Isracann Advises on Recent Activities and 2022 Outlook

VANCOUVER, British Columbia, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becom...

3 years ago - GlobeNewsWire

Isracann Appoints Operational Expert Phil Floucault as CEO and Grants Options

VANCOUVER, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becomi...

3 years ago - GlobeNewsWire

Isracann Receives Foreign Owners License and Updates Israeli Cannabis Operations

License paves way for market penetration and growth opportunities License paves way for market penetration and growth opportunities

4 years ago - GlobeNewsWire

Isracann Prepares for Recreational Cannabis Opportunity in Israel

Dramatic Consumer Growth Predicted When Legalization Occurs Dramatic Consumer Growth Predicted When Legalization Occurs

4 years ago - GlobeNewsWire

Isracann Well Positioned for Israel's Cannabis Sector Growth in 2021

Activities in 2020 laid groundwork towards accelerated results Activities in 2020 laid groundwork towards accelerated results

4 years ago - GlobeNewsWire

Isracann Announces Launch of Early Warrant Exercise Incentive Program and Repricing

VANCOUVER, British Columbia, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becomi...

4 years ago - GlobeNewsWire